Mirae Asset Global Investments Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,978 shares of IOVA stock, worth $83,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,978
Previous 8,354
31.41%
Holding current value
$83,981
Previous $66,000
56.06%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$209 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$204 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$184 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$101 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.21B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...